企業プロフィール
Eloxx 株価・ニュース・カタリスト
- ティッカー:
- ELOX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
19.99 USD (-4.70%)
終値
最終更新: 2026年8月24日
—
時価総額
株価変動の要因
As of Aug 24, 2026, ELOX closed down 4.70% at $19.99. No new same-company headline was identified in the current news window.
企業概要
事業概要
Eloxx Pharmaceuticals was a biotechnology company focused on rare disease and nonsense-mutation biology. Its story was built around precision approaches to difficult inherited disorders.
所在地とセクター分類
Eloxx was headquartered in the United States and listed on NASDAQ. It sat in rare-disease biotechnology.
ビジネスモデルの特徴
The business depended on translational progress, clinical validation, and the ability to keep a narrow pipeline funded. Investors generally watched early data and strategic changes.
バイオ業界での位置付け
Eloxx occupies the historical rare-disease biotech bucket. Its value proposition was always tied to limited assets and the market's patience for development risk.
今後のカタリスト
- Eloxx’s catalysts are its nonsense-mutation and rare-disease pipeline, plus any update that clarifies whether the company can still keep the translational story alive. The next step matters because the company still needs clinical proof.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。